The findings are the latest setback for weight loss medicines that target a specific cannabinoid receptor and are meant to ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

The results could pave the way for Datroway to supplant chemotherapy in certain triple-negative tumors, adding to existing ...

The Italian drugmaker will pay as much as $115 million in upfront and near-term payments in a deal that gives it rights to a ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...

In a Phase 2 trial, a drug at the center of the $4.9 billion deal matched the type of weight loss trajectory seen in testing ...

The biotech is starting up with partial rights to a drug that’s approved in multiple Asian countries and its executives see ...

George Tidmarsh criticized Aurinia’s lupus drug in a later-retracted social media post. Elsewhere, the FDA approved a new ...

The decision to clear another mifepristone generic sparked political backlash. Elsewhere, Medicare delayed a decision on whether to subject “combination” drugs to pricing negotiations, and a cancer ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...

The funding lapse triggered by the U.S. government shutdown is the latest test for an agency that’s already dealt with ...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...